Ofatumumab and Bendamustine in Previously Treated Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Bendamustine (Primary) ; Ofatumumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Registrational; Therapeutic Use
- 12 Mar 2015 Planned End Date changed from 1 Jul 2015 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 12 Mar 2015 Planned primary completion date changed to 1 May 2014 as reported by ClinicalTrials.gov.
- 08 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.